# Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

> **NCT07007286** · — · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 1500 (estimated)

## Conditions studied

- HBV
- HCC

## Interventions

- **DRUG:** ETV,TDF,TAF,TMF combination with PEG IFNα-2b
- **DRUG:** ETV,TDF,TAF or TMF

## Key facts

- **NCT ID:** NCT07007286
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2032-01
- **Final completion:** 2032-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07007286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07007286, "Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07007286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*